Data Presented at ACC 2013 Confirms Use of Corus® CAD in Women with Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions by longitudeadmin | Mar 11, 2013 | Portfolio News
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx® by longitudeadmin | Mar 11, 2013 | Portfolio News
PixelOptics Re-Emerges With Plan to Introduce Second Generation of Empower Eyewear by longitudeadmin | Mar 8, 2013 | Portfolio News
Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV® (acetaminophen) Injection by longitudeadmin | Mar 6, 2013 | Portfolio News
Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders by longitudeadmin | Mar 5, 2013 | Portfolio News